Laura Core
Pediatrics · Knoxville, TNNPI 1568893717
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,606 of the $6,443 with a category attached, or 71.5%. 24 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 24.2% of the total. Among pediatrics clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 194 payments — averaging $33.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$2K
- AstraZeneca$946
- Kedrion Biopharma Inc.$700
- CSL Behring$699
- Sanofi$612
- Takeda Pharmaceuticals U.S.A., Inc.$570
- plus $1K from 18 others
What the payments were for
- Consulting fees$75012%
- Speaking & faculty fees$70011%
- Food & beverage$4,60671%
- Education$3876%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 40 | $1,560 |
| AstraZeneca | 43 | $946 |
| Kedrion Biopharma Inc. | 1 | $700 |
| CSL Behring | 21 | $699 |
| Sanofi | 19 | $612 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $570 |
| GSK | 22 | $470 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Grifols USA, LLC | 5 | $96 |
| Amgen | 4 | $96 |
| Kaleo, Inc. | 4 | $81 |
| Pfizer | 4 | $79 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $76 |
| Genentech USA, Inc. | 3 | $62 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| Novartis | 2 | $40 |
| Pharming Healthcare, Inc. | 1 | $38 |
| Hospira, Inc. | 2 | $34 |
| Lilly USA, LLC | 1 | $29 |
| ADMA Biomanufacturing LLC | 1 | $26 |
| Optinose US, Inc. | 1 | $25 |
| AbbVie | 1 | $24 |
| Octapharma USA, Inc. | 1 | $17 |
| Blueprint Medicines Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,443 in reported general payments places this provider in the 95th percentile of 1,338 pediatrics providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 31 | $32,033 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $11,099 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $4,464 |
| Arnuity ElliptaFluticasone Furoate | 12 | $3,283 |
| Azelastine Hcl | 89 | $3,264 |
| Fluticasone Propionate | 117 | $1,714 |
| Montelukast Sodium | 109 | $1,153 |
| Ipratropium Bromide | 25 | $663 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $429 |
| Famotidine | 12 | $127 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Arnuity Ellipta | $470 | $35,31643 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $946 | $15,56328 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,338 pediatrics providers in Tennessee.
Other pediatrics in Knoxville
- Lauren JohnsonKnoxville$23K
- Grace LawleyKnoxville$5K
- Lori MiddletonKnoxville$5K
- Laura TrenthamKnoxville$4K
- Timothy FrazierKnoxville$4K
- Chelsea WatkinsKnoxville$4K
- Kelly EarnestKnoxville$4K
- Mary MillerKnoxville$3K
- Phillip NoeKnoxville$3K
- Madeline EllisGallatin$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.